These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26352775)

  • 21. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
    Lin F; Zhang PL; Yang XJ; Prichard JW; Lun M; Brown RE
    Ann Clin Lab Sci; 2006; 36(3):283-93. PubMed ID: 16951269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation.
    Inamura K; Fujiwara M; Togashi Y; Nomura K; Mukai H; Fujii Y; Yamamoto S; Yonese J; Fukui I; Ishikawa Y
    Am J Surg Pathol; 2012 Jan; 36(1):35-42. PubMed ID: 22173116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.
    Minner S; Rump D; Tennstedt P; Simon R; Burandt E; Terracciano L; Moch H; Wilczak W; Bokemeyer C; Fisch M; Sauter G; Eichelberg C
    Cancer; 2012 Mar; 118(5):1268-75. PubMed ID: 22161775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
    Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
    Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
    Marsaud A; Dadone B; Ambrosetti D; Baudoin C; Chamorey E; Rouleau E; Lefol C; Roussel JF; Fabas T; Cristofari G; Carpentier X; Michiels JF; Amiel J; Pedeutour F
    Genes Chromosomes Cancer; 2015 Jun; 54(6):369-82. PubMed ID: 25820192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.
    Peckova K; Vanecek T; Martinek P; Spagnolo D; Kuroda N; Brunelli M; Vranic S; Djuricic S; Rotterova P; Daum O; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Dubova M; Kalusova K; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2014 Dec; 18(6):351-7. PubMed ID: 25438924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
    Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
    Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging tyrosine kinase inhibitors for the treatment of renal cancer.
    Iacovelli R; Albiges L; Escudier B
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):379-92. PubMed ID: 25982181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of gene expression analysis of renal cell carcinoma.
    Leppert JT; Pantuck AJ
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal cell carcinoma with Xp 11.2 translocation as a second tumor in a long-term survivor of advanced neuroblastoma.
    Al-Mashaikhi N; Yang J; Terry J; Barr R
    Pediatr Hematol Oncol; 2015 Apr; 32(3):215-22. PubMed ID: 25551622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.
    Zhang YD; Wu CJ; Wang Q; Zhang J; Wang XN; Liu XS; Shi HB
    AJR Am J Roentgenol; 2015 Aug; 205(2):W193-201. PubMed ID: 26204307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy.
    Park JY; Lee JL; Baek S; Eo SH; Go H; Ro JY; Cho YM
    Hum Pathol; 2014 Jul; 45(7):1437-44. PubMed ID: 24784922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
    Choi YA; Kim CK; Park SY; Cho SW; Park BK
    AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal cancer: cytogenetic and molecular genetic aspects.
    Meloni-Ehrig AM
    Am J Med Genet; 2002 Oct; 115(3):164-72. PubMed ID: 12407697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
    Song HC; Sun N; Zhang WP; He L; Fu L; Huang C
    J Pediatr Surg; 2014 Apr; 49(4):539-42. PubMed ID: 24726108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma.
    Khella HW; Scorilas A; Mozes R; Mirham L; Lianidou E; Krylov SN; Lee JY; Ordon M; Stewart R; Jewett MA; Yousef GM
    Am J Pathol; 2015 Mar; 185(3):693-703. PubMed ID: 25572155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
    Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
    Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.